Laporan Laba Rugi BETA - TTM - Beta Drugs Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Beta Drugs Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31
Revenue	956	1,058	1,161	1,345	1,528	1,683	1,838	1,960	2,081	2,176	2,271	2,416	2,560	2,759	2,957	3,152	3,347	3,486	3,624
Change (%)		10.75	9.71	15.81	13.65	10.14	9.21	6.61	6.20	4.56	4.36	6.36	5.98	7.76	7.20	6.60	6.19	4.12	3.96
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	583	654	723	838	953	1,038	1,123	1,173	1,223	1,260	1,297	1,396	1,491	1,648	1,814	1,913	2,012	2,066	2,120
Change (%)		12.13	10.58	15.92	13.73	8.95	8.22	4.42	4.23	3.08	2.87	7.67	6.78	10.57	10.03	5.46	5.18	2.68	2.61
% of Revenue	61.00	61.75	62.24	62.30	62.35	61.67	61.11	59.86	58.75	57.92	57.09	57.80	58.24	59.76	61.34	60.68	60.10	59.27	58.50

Gross Operating Profit	373	405	438	507	575	645	715	787	859	916	974	1,019	1,069	1,110	1,143	1,239	1,336	1,420	1,504
Change (%)		8.61	8.30	15.63	13.51	12.11	10.80	10.05	9.13	6.66	6.41	4.61	4.88	3.84	3.00	8.40	7.75	6.30	5.93
% of Revenue	39.00	38.25	37.76	37.70	37.65	38.33	38.89	40.14	41.25	42.08	42.91	42.20	41.76	40.24	38.66	39.32	39.90	40.73	41.50

SG&A	103	119	121	132	143	156	170	190	210	226	243	249	254	266	277	298	319	329	340
Change (%)		16.55	1.53	8.75	8.05	9.62	8.77	11.76	10.52	7.82	7.25	2.41	2.35	4.36	4.18	7.57	7.03	3.32	3.22
% of Revenue	10.73	11.29	10.45	9.81	9.33	9.28	9.25	9.69	10.09	10.40	10.69	10.29	9.94	9.63	9.36	9.44	9.52	9.44	9.38

R&D
Change (%)
% of Revenue

OpEx	818	899	982	1,119	1,257	1,370	1,484	1,579	1,675	1,758	1,841	1,958	2,075	2,266	2,456	2,623	2,789	2,896	3,003
Change (%)		9.93	9.19	13.98	12.27	9.04	8.29	6.42	6.03	4.97	4.73	6.37	5.98	9.17	8.40	6.79	6.36	3.82	3.68
% of Revenue	85.61	84.97	84.57	83.24	82.22	81.40	80.72	80.58	80.45	80.77	81.06	81.06	81.07	82.13	83.05	83.20	83.33	83.09	82.86

Operating Income	138	159	179	225	272	313	354	381	407	419	430	457	485	493	501	530	558	590	621
Change (%)		15.65	12.64	25.84	20.53	15.23	13.21	7.39	6.88	2.88	2.80	6.32	5.95	1.71	1.69	5.67	5.36	5.63	5.33
% of Revenue	14.39	15.03	15.43	16.76	17.78	18.60	19.28	19.42	19.55	19.23	18.94	18.94	18.93	17.87	16.95	16.80	16.67	16.91	17.14

Interest Expense	-27	-23	-22	-21	-19	-19	-18	-19	-20	-21	-23	-24	-25	-26	-27	-29	-31	-51	-70
Change (%)		-14.63	-4.54	-6.15	-6.55	-4.07	-4.25	5.87	5.55	7.03	6.57	5.04	4.80	3.34	3.23	8.53	7.86	61.51	38.08
% of Revenue	-2.85	-2.20	-1.91	-1.55	-1.27	-1.11	-0.97	-0.97	-0.96	-0.98	-1.00	-0.99	-0.98	-0.94	-0.91	-0.92	-0.94	-1.45	-1.93

Net Income	95	106	117	150	183	216	248	269	289	298	307	327	348	356	364	387	410	417	424
Change (%)		11.87	10.61	28.02	21.89	17.86	15.15	8.22	7.60	3.13	3.03	6.57	6.17	2.42	2.36	6.26	5.89	1.73	1.70
% of Revenue	9.92	10.01	10.10	11.16	11.97	12.81	13.51	13.71	13.89	13.70	13.53	13.55	13.58	12.90	12.32	12.28	12.25	11.97	11.71

Source: Capital IQ

Beta Drugs Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)